Leading Swedish biotechnology company Atlas Antibodies provides affinity-purified monoclonal and polyclonal antibodies and control antigens that drive cutting-edge research worldwide. Focus areas include proteomics, tissue analysis, and targeted protein studies across cells, tissues, and organs. With roots in the Human Protein Atlas project, Atlas Antibodies is committed to developing products that are selective and specific for their target proteins through extensive validation processes that ensure reproducible results.
Worldwide, Atlas Antibodies is perhaps most widely recognized for their PrecisA Monoclonals™ and Triple A Polyclonals™, which offer exceptional specificity and validation across human tissues. Their innovative MolBoolean™ technology enables simultaneous detection of both free and interacting fractions for two protein targets. Using PrEST Antigens™, researchers can access the same immunogens used to generate Atlas antibodies, providing valuable control reagents for blocking experiments and positive assay controls.
Quality products, comprehensive scientific support, and rigorous validation are integral to Atlas Antibodies' mission of advancing scientific discovery. Their recent acquisitions of HistoCyte Laboratories and evitria further expand their capabilities in histopathology controls and recombinant antibody expression services.